Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms

The 2016 World Health Organization classification introduced a number of genes with somatic mutations and a category for germline predisposition syndromes in myeloid neoplasms. We have designed a comprehensive next-generation sequencing assay to detect somatic mutations, translocations, and germline...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Kim, Borahm, Lee, Hyeonah, Jang, Jieun, Kim, Soo-Jeong, Lee, Seung-Tae, Cheong, June-Won, Lyu, Chuhl Joo, Min, Yoo Hong, Choi, Jong Rak
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402635/
https://ncbi.nlm.nih.gov/pubmed/30840646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0212228
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires